Ikarian Capital, LLC Sensei Biotherapeutics, Inc. Call Options Transaction History
Ikarian Capital, LLC
- $573 Million
- Q3 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding SNSE
# of Institutions
22Shares Held
2.23MCall Options Held
0Put Options Held
0-
Vanguard Group Inc Valley Forge, PA619KShares$284,6280.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny216KShares$99,1630.0% of portfolio
-
Boothbay Fund Management, LLC New York, NY173KShares$79,5040.0% of portfolio
-
Geode Capital Management, LLC Boston, MA163KShares$75,0430.0% of portfolio
-
Susquehanna International Group, LLP Bala Cynwyd, PA90.4KShares$41,5960.0% of portfolio
About Sensei Biotherapeutics, Inc.
- Ticker SNSE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 30,720,300
- Market Cap $14.1M
- Description
- Sensei Biotherapeutics, Inc., a biopharmaceutical company, engages in the discovery and development of immunotherapies with an initial focus on treatments for cancer. It develops proprietary ImmunoPhage platform, an immunotherapy approach that is designed to utilize bacteriophage to induce a focused and coordinated innate and adaptive immune res...